Comparison of patients with long-term follow-up (n = 71)
| Parameter . | Stable (n = 45) . | Clonal drift (n = 26) . | P . |
|---|---|---|---|
| Clone size, % | 61 ± 30 | 36 ± 26 | <.001* |
| ACC, cells/μL | 3140 ± 6348 | 794 ± 1457 | .008* |
| Lymphocytosis, proportion (%) | 16/45 (35) | 4/26 (25) | .058 |
| B-cell disorder, proportion (%) | 20/45 (44) | 6/26 (23) | .081 |
| HLA A2 homozygous, proportion (%) | 9/44 (20) | 0/23 (0) | .023* |
| HLA A29, proportion (%) | 1/44 (2) | 4/23 (17) | .044* |
| HLA B7, proportion (%) | 16/41 (39) | 4/23 (17) | .095 |
| HLA class I homozygous, proportion (%) | 16/44 (36) | 3/23 (13) | .051 |
| Asymptomatic, proportion (%) | 5/45 (11) | 4/26 (15) | .715 |
| Parameter . | Stable (n = 45) . | Clonal drift (n = 26) . | P . |
|---|---|---|---|
| Clone size, % | 61 ± 30 | 36 ± 26 | <.001* |
| ACC, cells/μL | 3140 ± 6348 | 794 ± 1457 | .008* |
| Lymphocytosis, proportion (%) | 16/45 (35) | 4/26 (25) | .058 |
| B-cell disorder, proportion (%) | 20/45 (44) | 6/26 (23) | .081 |
| HLA A2 homozygous, proportion (%) | 9/44 (20) | 0/23 (0) | .023* |
| HLA A29, proportion (%) | 1/44 (2) | 4/23 (17) | .044* |
| HLA B7, proportion (%) | 16/41 (39) | 4/23 (17) | .095 |
| HLA class I homozygous, proportion (%) | 16/44 (36) | 3/23 (13) | .051 |
| Asymptomatic, proportion (%) | 5/45 (11) | 4/26 (15) | .715 |
indicates statistical significance at α = 0.05.